A comparative study on safety and immunogenicity of an inactivated hepatitis A vaccine in HBsAg carriers and healthy children / 中华实验和临床病毒学杂志
Chinese Journal of Experimental and Clinical Virology
;
(6): 380-381, 2002.
Artículo
en Chino
| WPRIM
| ID: wpr-250563
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate safety and immunogenicity of inactivated hepatitis A vaccine in HBsAg carriers and healthy children.</p><p><b>METHODS</b>One hundred and twenty-one healthy children and ten HBsAg carriers, aged 1-10 years HAV susceptible were enrolled in the study. The inactivated hepatitis A vaccine was produced by Tangshan Biogenetic Company. The dosage of the vaccine was 1000 U/Dosage and 500 U/Dosage. The vaccination schedule was six month apart for two injections. The serum anti-HAV level was detected with EIA at one month after first injection and at one and six month after the booster injection, respectively.</p><p><b>RESULTS</b>The anti-HAV appeared in all the children. One month after the booster injection, the serum anti-HAV level in children vaccinated 500 U/Dosage was 4684.9 mIU and 4535.6 mIU, respectively and in the children vaccinated 1000 U/Dosage, 5399.8 mIU and 7347.1 mIU, respectively. The anti-HAV level was not statistically different between the two groups of children. There was no adverse reaction after the vaccination. The anti-HAV level was still high one year after first injection.</p><p><b>CONCLUSIONS</b>The data indicated that the safety and immunogenicity of the domestic inactivated hepatitis A vaccine were excellent in both groups of children.</p>
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Sangre
/
Vacunas de Productos Inactivados
/
Inmunización
/
Vacunas contra la Hepatitis A
/
Anticuerpos de Hepatitis A
/
Alergia e Inmunología
/
Antígenos de Superficie de la Hepatitis B
Límite:
Niño
/
Child, preschool
/
Humanos
/
Lactante
Idioma:
Chino
Revista:
Chinese Journal of Experimental and Clinical Virology
Año:
2002
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS